苏豪弘业股份有限公司关于修改《公司章程》的公告

Core Viewpoint - Suhao Hongye Co., Ltd. plans to amend its Articles of Association to include "sales of Class I medical devices" in its business scope and adjust the powers of the shareholders' meeting, board of directors, and general manager [1][2][4]. Group 1: Amendments to Articles of Association - The board of directors approved the proposal to amend the Articles of Association during the sixth meeting of the eleventh board on December 11, 2025, with a unanimous vote of 6 in favor [4][5]. - The amendments will also include adjustments to the management of shareholder meetings and the board of directors, as well as an increase in registered capital following the completion of the restricted stock incentive plan [1][2]. Group 2: Governance and Management System Changes - The board approved several amendments to governance-related systems, including the Information Disclosure Management System, Insider Information Knowledge Person Registration Management System, Investor Relations Management Measures, and others, all receiving unanimous support [6][7][8][9][10][12][14]. - These amendments are also subject to approval by the shareholders' meeting [11]. Group 3: 2026 Annual Related Transactions - The company has estimated that the total amount of related transactions for 2026 will not exceed 50 million yuan [21]. - The board meeting on December 11, 2025, approved the expected related transactions, with related directors abstaining from voting, ensuring compliance with governance standards [22]. - The related transactions are deemed necessary for daily operations and will not affect the company's independence or reliance on such transactions [26]. Group 4: Upcoming Shareholders' Meeting - The third temporary shareholders' meeting for 2025 is scheduled for December 29, 2025, at 14:00, to be held at the company's headquarters [28]. - Voting will be conducted through both on-site and online methods, with specific timeframes outlined for participation [29][30].